OBJECTIVE: Socioeconomic status (SES) is inversely associated with coronary heart disease (CHD) risk. Cumulative pathogen burden may also predict future CHD. The hypothesis was tested that lower SES is associated with a greater pathogen burden, and that pathogen burden accounts in part for SES differences in cardiovascular risk factors. METHODS: This was a cross-sectional observational study involving the clinical examination of 451 men and women aged 51-72 without CHD, recruited from the Whitehall II epidemiological cohort. SES was defined by grade of employment, and pathogen burden by summing positive serostatus for Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus 1. Cardiovascular risk factors were also assessed. RESULTS: Pathogen burden averaged 1.94 (SD) 0.93 in the lower grade group, compared with 1.64 (0.97) and 1.64 (0.93) in the intermediate and higher grade groups (p = 0.011). Pathogen burden was associated with a higher body mass index, waist/hip ratio, blood pressure and incidence of diabetes. There were SES differences in waist/hip ratio, high-density lipoprotein-cholesterol, fasting glucose, glycated haemoglobin, lung function, smoking and diabetes. The SES gradient in these cardiovascular risk factors was unchanged when pathogen burden was taken into account statistically. CONCLUSIONS: Although serological signs of infection with common pathogens are more frequent in lower SES groups, their distribution across the social gradient does not match the linear increases in CHD risk present across higher, intermediate and lower SES groups. Additionally, pathogen burden does not appear to mediate SES differences in cardiovascular risk profiles.
OBJECTIVE: Socioeconomic status (SES) is inversely associated with coronary heart disease (CHD) risk. Cumulative pathogen burden may also predict future CHD. The hypothesis was tested that lower SES is associated with a greater pathogen burden, and that pathogen burden accounts in part for SES differences in cardiovascular risk factors. METHODS: This was a cross-sectional observational study involving the clinical examination of 451 men and women aged 51-72 without CHD, recruited from the Whitehall II epidemiological cohort. SES was defined by grade of employment, and pathogen burden by summing positive serostatus for Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus 1. Cardiovascular risk factors were also assessed. RESULTS: Pathogen burden averaged 1.94 (SD) 0.93 in the lower grade group, compared with 1.64 (0.97) and 1.64 (0.93) in the intermediate and higher grade groups (p = 0.011). Pathogen burden was associated with a higher body mass index, waist/hip ratio, blood pressure and incidence of diabetes. There were SES differences in waist/hip ratio, high-density lipoprotein-cholesterol, fasting glucose, glycated haemoglobin, lung function, smoking and diabetes. The SES gradient in these cardiovascular risk factors was unchanged when pathogen burden was taken into account statistically. CONCLUSIONS: Although serological signs of infection with common pathogens are more frequent in lower SES groups, their distribution across the social gradient does not match the linear increases in CHD risk present across higher, intermediate and lower SES groups. Additionally, pathogen burden does not appear to mediate SES differences in cardiovascular risk profiles.
Authors: J Danesh; P Whincup; S Lewington; M Walker; L Lennon; A Thomson; Y-K Wong; X Zhou; M Ward Journal: Eur Heart J Date: 2002-03 Impact factor: 29.983
Authors: J De Backer; R Mak; D De Bacquer; L Van Renterghem; E Verbraekel; M Kornitzer; G De Backer Journal: Atherosclerosis Date: 2002-02 Impact factor: 5.162
Authors: S Kiechl; G Egger; M Mayr; C J Wiedermann; E Bonora; F Oberhollenzer; M Muggeo; Q Xu; G Wick; W Poewe; J Willeit Journal: Circulation Date: 2001-02-27 Impact factor: 29.690
Authors: Abhiram Prasad; Jianhui Zhu; Julian P J Halcox; Myron A Waclawiw; Stephen E Epstein; Arshed A Quyyumi Journal: Circulation Date: 2002-07-09 Impact factor: 29.690
Authors: Jean Louis Georges; Hans J Rupprecht; Stefan Blankenberg; Odette Poirier; Christoph Bickel; Gerd Hafner; Viviane Nicaud; Jürgen Meyer; François Cambien; Laurence Tiret Journal: Am J Cardiol Date: 2003-09-01 Impact factor: 2.778
Authors: Paul Moayyedi; Anthony T R Axon; Richard Feltbower; Sara Duffett; Will Crocombe; David Braunholtz; I D Gerald Richards; Anthony C Dowell; David Forman Journal: Int J Epidemiol Date: 2002-06 Impact factor: 7.196
Authors: Cairistine Grahame-Clarke; Norman N Chan; Dawn Andrew; Geoff L Ridgway; D John Betteridge; Vincent Emery; Helen M Colhoun; Patrick Vallance Journal: Circulation Date: 2003-08-04 Impact factor: 29.690
Authors: Kyle W Murdock; Christopher P Fagundes; M Kristen Peek; Vansh Vohra; Raymond P Stowe Journal: Psychoneuroendocrinology Date: 2016-06-25 Impact factor: 4.905
Authors: Christopher P Fagundes; Jeanette M Bennett; Catherine M Alfano; Ronald Glaser; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; Lisa D Yee; William E Carson; William B Farrar; William B Malarkey; Min Chen; Janice K Kiecolt-Glaser Journal: Health Psychol Date: 2011-10-17 Impact factor: 4.267
Authors: Christopher P Fagundes; Ronald Glaser; Catherine M Alfano; Jeanette M Bennett; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; Lisa D Yee; William E Carson; William B Farrar; William B Malarkey; Janice K Kiecolt-Glaser Journal: Brain Behav Immun Date: 2011-10-02 Impact factor: 7.217
Authors: Christopher P Fagundes; Ronald Glaser; William B Malarkey; Janice K Kiecolt-Glaser Journal: Health Psychol Date: 2012-07-02 Impact factor: 4.267
Authors: Kerry W S Ko; David B Corry; Cory F Brayton; Antoni Paul; Lawrence Chan Journal: Biochem Biophys Res Commun Date: 2009-04-22 Impact factor: 3.575
Authors: Christopher P Fagundes; Lisa M Jaremka; Ronald Glaser; Catherine M Alfano; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; Lisa D Yee; William E Carson; William B Farrar; William B Malarkey; Min Chen; Janice K Kiecolt-Glaser Journal: Brain Behav Immun Date: 2014-06-16 Impact factor: 7.217